REV Clinical

COMPANY PROFILE

REV Clinical is a US-based global contract research organisation (CRO) providing end-to-end clinical trial services to pharmaceutical and biotechnology companies.

Description

Building on its history as CBCC Global Research, REV Clinical is a U.S.-based global CRO focused on helping emerging and mid-sized biopharma companies accelerate clinical development with speed, flexibility, and operational precision.
With a growing international footprint, REV Clinical delivers capital-efficient execution across multiple therapeutic areas, from first-in-human through late-phase studies. The company is known for its nimble, transparent approach and its ability to operate as a true extension of sponsor teams, helping advance complex studies with reliability, excellence, and velocity.

Key products and services

Clinical trial design and operations

  • Phase I–IV clinical trial management
  • Study design, feasibility and execution
  • Site selection, monitoring and project management

Regulatory and submission expertise

  • Regulatory strategy and planning
  • IND/NDA submission support
  • Health authority interactions and compliance

Biometrics and data management

  • Biostatistics and statistical programming
  • Clinical data management and analysis
  • Data reporting and analytics

Medical writing and scientific services

  • Clinical study reports and regulatory documentation
  • Scientific and medical writing services
  • Health economics and outcomes research (HEOR) support

Global Velocity Network™

  • Multi-regional site network across US, India and Australia
  • Accelerated patient recruitment and study start-up
  • Flexible global trial execution capabilities

Trial rescue and quality services

  • Clinical trial rescue and recovery solutions
  • Quality assurance and compliance support
  • Risk mitigation and study optimisation

By combining scientific expertise, global operational networks and a flexible delivery model, REV Clinical supports life sciences companies in accelerating clinical development and improving trial outcomes. Its focus on speed, quality and collaborative execution positions the company as a strategic CRO partner for sponsors seeking efficient and reliable clinical trial delivery.

Contact Information

Address
6501 Truxtun Avenue Bakersfield, California 93309 United States

FREE REPORT CDMO LIVE EUROPE 2026

112 pages of insight from biopharma outsourcing leaders